CN1276765C - Incense fumigating agent for coryza - Google Patents
Incense fumigating agent for coryza Download PDFInfo
- Publication number
- CN1276765C CN1276765C CN 200410067818 CN200410067818A CN1276765C CN 1276765 C CN1276765 C CN 1276765C CN 200410067818 CN200410067818 CN 200410067818 CN 200410067818 A CN200410067818 A CN 200410067818A CN 1276765 C CN1276765 C CN 1276765C
- Authority
- CN
- China
- Prior art keywords
- oil
- rhinitis
- present
- incense
- symptom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to an incense fumigating agent for coryza, which is prepared from the refined oil ingredients of six aromatic plants by volume percent: 18.0% to 19.0% of tea tree oil, 17.0 to 18.5% of lavander oil, 9.0% to 10.0% of thyme oil, 26.5% to 27.5% of lemon oil, 17.0% to 18.5% of peppermint oil and 9.0% to 10.0% of sweet basil oil. The present invention has the functions of effectively reducing the secretions of nasal mucous membrane, allaying rhinobyon, relieving headache, improving anaphylaxis and enhancing immunizing power; simultaneously, the present invention without toxic or side effect has strong antiphlogosis, sterilization and antivirus, and a certain fever removing function.
Description
Technical field
The present invention relates to a kind of perfumed incense for the treatment of rhinitis, utilize the derived essential oil of fragrant plant formulated, rhinitis is had alleviate and the improvement effect, belong to the medicines and health protection technical field.
Background technology
Rhinitis is a common disease, be divided into two kinds, a kind of is because the rhinitis that antibacterial and virus cause, mostly be acute condition of illness, can be treated by anti-inflammation drugs, another kind is an allergic rhinitis, is that the anaphylaxis excitor substance by the external world causes, the use of anti-inflammation drugs does not almost have therapeutical effect, can only alleviate the rhinitis symptom by Claritin.Two kinds of common reveal any symptomses of rhinitis are sneeze, rhinorrhea, headache.Institute's difference for the former usually show as the fever patient few, flow clear nasal mucus, the headache phenomenon comparatively serious; The latter show as the patient many with the symptom of having a fever, the pus nasal mucus is arranged.Which kind of rhinitis all can be finally because the expansion of blood vessel and mucous increase cause nasal obstruction, more because the anoxia that hypopnea causes causes headache.Medical market has two classes at the medication of rhinitis at present: a class is middle medicament, and a class is a western medicine formulation.The characteristics of medicament are to utilize the nonvolatile medicinal ingredient of Chinese crude drug to be made into prescription among the overwhelming majority, and the direct drop of nose is treated; The characteristics of western medicine formulation are that most compositions are synthetic all, and filling a prescription is single component, or the only assembly of a small amount of several single components, and common several also can only be the short time to improve the rhinitis symptom.
Some volatile essential oil compositions that extract from fragrant plant have anti-inflammatory, antibacterium, antiviral effect, and mucus is had dissolution, anti-mucositis effect, the effect that also has antiallergic simultaneously and improve immunity.States such as America and Europe and Japan utilize the composition of the quintessence oil of these fragrant plants, improve and alleviate the nasal inflammation shape by inhalation, nebulization and quintessence oil massotherapy and obtained some good effects.These methods are included in the therapeutic scheme of aromatotherapy successively.As rhinitis prescription from German Susanne Fischer-Rizzi, used Angelica officinais, Herba Rosmarini Officinalis, lavandula angustifolia, Herba thymi vulgaris, five kinds of aromatic essential oil assembly of cypress form, have certain antiinflammatory, slightly eliminate the phlegm, kill antibacterial and invigorate blood circulation and pressor effect.And China does not have good medical procedure and therapeutic scheme for rhinitis especially allergic rhinitis at present, utilizes the patented product that aromatic essential oil is alleviated and improved the rhinitis symptom seldom to see especially.
Summary of the invention
The objective of the invention is at the deficiencies in the prior art, a kind of perfumed incense for the treatment of rhinitis is provided, adopt the preparation of All Pure Nature fragrant plant, can have the cardinal symptom that rhinitis showed and improve fast and effectively and mitigation, esy to use, safe and reliable.
For realizing such purpose, the present invention is in the derived essential oil of having studied some kinds of fragrant plants and function, and passed through and repeatedly experimental results show that to after safe and effective, with six kinds of aromatic essential oil compositions: tea tree oil, Oleum lavandula angustifolia, thyme oil, Fructus Citri Limoniae oil, Herba Ocimi (Herba Ocimi Pilosi) and Fructus Piperis peppermint oil mix according to a certain percentage, formulated a kind of rhinitis perfumed incense, the percent by volume of each composition is: tea tree oil 18.0%-19.0%, Oleum lavandula angustifolia 17.0-18.5%, thyme oil 9.0%-10.0%, Fructus Citri Limoniae oil 26.5%-27.5%, Fructus Piperis peppermint oil 17.0%-18.5%, basil oil 9.0%-10.0%.
Among the present invention, thyme oil has strong sterilizing power, suppresses the vigor of bacterial enzyme, and staphylococcus is caused death, and suppresses viral growth, promotes leukocyte to generate, and can dissolve the mucus that nasal cavity produces, and flu, rhinitis, pertussis symptom are had phlegm-dispelling functions when producing.In this prescription, play sterilization, suppress nasal cavital mucus.Tea tree oil has very strong anti-infection ability, can sterilizing, and effective to fungus especially, have the function that improves body immunity.That Fructus Citri Limoniae oil has is antibiotic, alleviate all respiratory apparatus such as throat, nasal cavity function that infects and bring down a fever etc., effective to paranasal sinus inflammation, flu, cough, blood circulation promoting, and the treatment migraine has citris aromas.Oleum lavandula angustifolia has calmness, antiinflammatory sterilization, helps the discharge of snotter, and various the infections diseases of throat are had improve and the mitigation effect, and the fragrance gentleness.Basil oil can relax headache and cephalagra, nasal obstruction, influenza, asthma is had the effect that slows down, and have fragrant and sweet abnormal smells from the patient.Fructus Piperis peppermint oil has the effect of sedation-analgesia, promotes snotter to discharge, and to alleviating nasal obstruction effectively, also has the antibiotic effect of stabilizing, diminishing inflammation, and has refrigerant sense.
After above-mentioned six kinds of aromatic essential oil compositions mixing, get the 0.3ml-0.6ml (about 6-12 drips) of its mixture, join in the 1L pure water, carry out fragrance and fumigate.The rhinitis severe patient uses once every day, and each ten minutes, a week was a course of treatment; Moderate person used once in two days, and each ten minutes, a week was a course of treatment.
Compare with the rhinitis medicine on the existing market, rhinitis perfumed incense of the present invention has significant effect.The present invention uses derived essential oil (every kind of aromatic essential oil all the is a lot of mixing active ingredients things) assembly of six kinds of aromatic plant volatilities to form, and has the combination effect of multiple composition.Because the characteristics that the derived essential oil molecular weight is little, permeability is strong, make derived essential oil directly enter nasal cavity by fumigation and steaming method, and can arrive other positions of human body rapidly, can have the cardinal symptom that rhinitis showed and improve fast and effectively and mitigation, nasal mucosa secretions is had elimination and dissolution, strengthen the permeability of nasal cavity, have sterilization and bacteriostasis, improve allergic symptom, improve immunity simultaneously.Fragrance component joyful in the rhinitis perfumed incense is ineffective to rhinitis merely, can also improve patient's mood, helps patient's rehabilitation.The present invention not only can be used in patient's the treatment, and can use popular season in flu, plays the effect of prevention and can not cause toxic and side effects.
The specific embodiment
Below by specific embodiment technical scheme of the present invention is further described.
Embodiment 1:
Get percent by volume and be 18.1% tea tree oil, 18.1% Oleum lavandula angustifolia, 9.2% thyme oil, 27.3% Fructus Citri Limoniae oil, 18.1% Fructus Piperis peppermint oil, 9.2% basil oil is mixed with the rhinitis perfumed incense after the mixing.
Get the 0.3ml-0.6ml (about 6-12 drips) of rhinitis perfumed incense, join in the 1L pure water, carry out fragrance and fumigate.The rhinitis severe patient uses once every day, and each ten minutes, a week was a course of treatment; Moderate person used once in two days, and each ten minutes, a week was a course of treatment.
Effect: reduce the generation of nasal mucosa secretions, can effectively alleviate permeability, alleviation headache that nasal obstruction improves nasal cavity, improve allergic symptom, improve immunity, strong sterilization, antiviral effect are arranged simultaneously, and certain effect of bringing down a fever is arranged.
Embodiment 2:
Get percent by volume and be 19.0% tea tree oil, 17.5% Oleum lavandula angustifolia, 10% thyme oil, 26.0% Fructus Citri Limoniae oil, 18.5% Fructus Piperis peppermint oil, 9.0% Herba Ocimi (Herba Ocimi Pilosi) is mixed with the rhinitis perfumed incense after the mixing.
Using method is with embodiment 1.
Effect: can effectively reduce the generation of nasal mucosa secretions, can effectively improve the nasal cavity permeability, alleviate the headache symptom, improve allergic symptom, improve immunity, have very strong antiinflammatory, sterilization, antivirus action.
Embodiment 3:
Get percent by volume and be 18.5% tea tree oil, 18.5% Oleum lavandula angustifolia, 9.5% thyme oil, 27.0% Fructus Citri Limoniae oil, 17.0% Fructus Piperis peppermint oil, 9.5% basil oil is mixed with the rhinitis perfumed incense after the mixing.
Using method is with embodiment 1.
Effect: reduce the generation of nasal mucosa secretions, improve the nasal cavity permeability, alleviate the headache symptom, improve allergic symptom, improve immunity, have strong antiinflammatory, sterilization, antivirus action.
Rhinitis perfumed incense of the present invention offers 50 patients and uses, and in questionnaire survey, 94% people thinks that the rhinitis symptom obviously alleviates after one month: nasal discharge obviously reduces, the symptom that alleviates, has a headache of having a stuffy nose is obviously alleviated, and health has obtained good improvement; It is general that 4% people thinks that the rhinitis symptom changes, and health has some improvement, and fragrance can be accepted; 2% people feels the few of improvement of rhinitis symptom, but fragrance can be accepted.
Claims (1)
1, a kind of perfumed incense for the treatment of rhinitis, it is characterized in that by percent by volume being the tea tree oil of 18.0%-19.0%, the Oleum lavandula angustifolia of 17.0-18.5%, the thyme oil of 9.0%-10.0%, the Fructus Citri Limoniae oil of 26.5%-27.5%, the Fructus Piperis peppermint oil of 17.0%-18.5%, the basil oil of 9.0%-10.0% is formulated.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410067818 CN1276765C (en) | 2004-11-04 | 2004-11-04 | Incense fumigating agent for coryza |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410067818 CN1276765C (en) | 2004-11-04 | 2004-11-04 | Incense fumigating agent for coryza |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1634349A CN1634349A (en) | 2005-07-06 |
| CN1276765C true CN1276765C (en) | 2006-09-27 |
Family
ID=34846698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410067818 Expired - Fee Related CN1276765C (en) | 2004-11-04 | 2004-11-04 | Incense fumigating agent for coryza |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1276765C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202010012255U1 (en) * | 2010-09-07 | 2010-11-18 | Krewel Meuselbach Gmbh | nasal spray |
| CN102266392B (en) * | 2011-08-01 | 2013-04-10 | 昆明创邦医疗器械有限公司 | Rhinitis patch |
| CN102319292A (en) * | 2011-08-04 | 2012-01-18 | 张玲环 | The essential oil component and the application thereof of treatment rhinitis |
| CN103877601A (en) * | 2014-03-25 | 2014-06-25 | 湖北科田植萃精华有限公司 | Extracted plant essence ventilation tablet and preparation method thereof |
| CN108014175A (en) * | 2017-11-30 | 2018-05-11 | 陈炳坤（天津）生物技术有限公司 | A kind of plant composition for being used to alleviate Rhinitis Symptoms |
-
2004
- 2004-11-04 CN CN 200410067818 patent/CN1276765C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1634349A (en) | 2005-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bhowmik et al. | Recent trends in Indian traditional herbs Syzygium aromaticum and its health benefits | |
| CN1927160A (en) | Gargle and its preparing process | |
| CN105340998A (en) | Natural traditional Chinese medicine mosquito-repellent incense and preparation method thereof | |
| CN102416154A (en) | Chinese eaglewood health-care sachet | |
| CN105534871A (en) | Mosquito-repelling and itching-relieving floral water and preparation method thereof | |
| Kumar et al. | Recent trends in Indian traditional herbs syzygium aromaticum and its health benefits | |
| CN1276765C (en) | Incense fumigating agent for coryza | |
| CN1839990A (en) | Natural plant compound formulation for preventing and treating human fowl enfluenze | |
| KR20030019097A (en) | Compositions for treatment and prevention of cold having antiviral activity | |
| CN103893559A (en) | Traditional Chinese medicinal drop for treating rhinitis and preparation method thereof | |
| CN110652544A (en) | Pharmaceutical composition for treating rhinitis and preparation method thereof | |
| CN103083404A (en) | Nasal cavity protective agent | |
| CN1179965A (en) | Antiviral anti-influenza spray and its preparing method | |
| CN111345531A (en) | Rhinitis health care mask | |
| CN1215884C (en) | Chinese medicine formula for preventing common cold by fumigating air to act respiratory tract and using method | |
| Jain et al. | Utilization of menthe, camphor, eucalyptus and other volatile oils in quick remedies for nasal congestion | |
| Al-Harrasi et al. | Essential Oils in the Treatment of Respiratory Tract Infections | |
| Mohan et al. | Naturopathy and endodontics–A synergistic approach | |
| CN103251701B (en) | Traditional Chinese medicine composition for treating rhinitis | |
| CN105920354A (en) | Throat inhalant for treating bronchiectasia | |
| CN108452213A (en) | A kind of Chinese medicine for treating rhinitis composition, Chinese medicine preparation and preparation method thereof | |
| Ferrara | Phytotherapy as a preventive and adjuvant for the rhinitis | |
| CN107397794B (en) | Rhinitis medicine composition and preparation method thereof | |
| CN1733074A (en) | Externally applied medicine for treating dermatosis | |
| CN1548127A (en) | Epidemic preventing fragrant pendant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060927 Termination date: 20091204 |